OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells
Jan Mueller, Roman R. Schimmer, Christian Koch, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 3, pp. 445-474
Open Access | Times Cited: 8
Jan Mueller, Roman R. Schimmer, Christian Koch, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 3, pp. 445-474
Open Access | Times Cited: 8
Showing 8 citing articles:
Recent advances of CAR-T cells in acute myeloid leukemia
Huan Deng, Qi Wang, Xiaodong Tong, et al.
Therapeutic Advances in Hematology (2025) Vol. 16
Open Access
Huan Deng, Qi Wang, Xiaodong Tong, et al.
Therapeutic Advances in Hematology (2025) Vol. 16
Open Access
Evaluating targeted therapies in older patients with TP53 -mutated AML
Jean Sabile, Ronan T. Swords, Jeffrey W. Tyner
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 9, pp. 1201-1218
Closed Access | Times Cited: 1
Jean Sabile, Ronan T. Swords, Jeffrey W. Tyner
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 9, pp. 1201-1218
Closed Access | Times Cited: 1
Impact of p53-associated acute myeloid leukemia hallmarks on metabolism and the immune environment
Monika Chomczyk, Luca Gazzola, Shubhankar Dash, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Monika Chomczyk, Luca Gazzola, Shubhankar Dash, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells
Laura Volta, Renier Myburgh, Christian Pellegrino, et al.
Leukemia (2024)
Open Access | Times Cited: 1
Laura Volta, Renier Myburgh, Christian Pellegrino, et al.
Leukemia (2024)
Open Access | Times Cited: 1
A Line in Shifting Sand: Can We Define and Target TP53 Mutated MDS?
Sarah Skuli, Andrew Matthews, Martin Carroll, et al.
Seminars in Hematology (2024)
Closed Access | Times Cited: 1
Sarah Skuli, Andrew Matthews, Martin Carroll, et al.
Seminars in Hematology (2024)
Closed Access | Times Cited: 1
Nontransplant treatment approaches for myeloid neoplasm with mutated TP53
Ansh Mehta, Marina Konopleva
Hematology (2024) Vol. 2024, Iss. 1, pp. 326-334
Closed Access | Times Cited: 1
Ansh Mehta, Marina Konopleva
Hematology (2024) Vol. 2024, Iss. 1, pp. 326-334
Closed Access | Times Cited: 1
Efficient Combinatorial Adaptor-Mediated Targeting of Acute Myeloid Leukemia with CAR T-Cells
Markus G. Manz, Laura Volta, Renier Myburgh, et al.
Research Square (Research Square) (2024)
Closed Access
Markus G. Manz, Laura Volta, Renier Myburgh, et al.
Research Square (Research Square) (2024)
Closed Access
Quantification of CAR T cell performance against acute myeloid leukemia using Bayesian inference
Saumil Shah, Jan Mueller, Michael Raatz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Saumil Shah, Jan Mueller, Michael Raatz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
